ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 16 filers reported holding ARIDIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,014 | -30.0% | 4,612 | 0.0% | 0.00% | – |
| Q1 2023 | $1,449 | -92.9% | 4,612 | -73.3% | 0.00% | – |
| Q4 2022 | $20,370 | +27.3% | 17,263 | -1.1% | 0.00% | – |
| Q3 2022 | $16,000 | -20.0% | 17,448 | -1.6% | 0.00% | – |
| Q2 2022 | $20,000 | -68.3% | 17,735 | -50.5% | 0.00% | – |
| Q1 2022 | $63,000 | -37.6% | 35,826 | -17.1% | 0.00% | – |
| Q4 2021 | $101,000 | -35.3% | 43,201 | +2.3% | 0.00% | – |
| Q3 2021 | $156,000 | -33.3% | 42,227 | +33.6% | 0.00% | – |
| Q2 2021 | $234,000 | +50.0% | 31,613 | +19.8% | 0.00% | – |
| Q1 2021 | $156,000 | +8.3% | 26,381 | +11.4% | 0.00% | – |
| Q4 2020 | $144,000 | -10.0% | 23,679 | +4.8% | 0.00% | – |
| Q3 2020 | $160,000 | +22.1% | 22,600 | +15.1% | 0.00% | – |
| Q2 2020 | $131,000 | +263.9% | 19,628 | +212.3% | 0.00% | – |
| Q1 2020 | $36,000 | +44.0% | 6,285 | +10.0% | 0.00% | – |
| Q4 2019 | $25,000 | +212.5% | 5,715 | +367.7% | 0.00% | – |
| Q3 2019 | $8,000 | -33.3% | 1,222 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | – | 1,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wealth Architects, LLC | 14,077 | $1,437 | 0.00% |